2023

2021

2020

2019

2018

2017

2016

2015

2014

Portefølje Naturvitenskap og teknologi ikon

Forskningssystemet

Portefølje Humaniora og samfunnsvitenskap ikon

Banebrytende forskning

Portefølje Samisk ikon

Samisk samfunn og kultur

Portefølje Demokrati, styring og fornyelse ikon

Demokrati og global utvikling

Portefølje Velferd, kultur og samfunn ikon

Velferd og utdanning

Portefølje Helse ikon

Helse

Portefølje Klima- og polarforskning ikon

Klima og miljø

Portefølje Landbasert mat, miljø og bioressurser ikon

Mat og bioressurser

Portefølje Energi, transport og lavutslipp ikon

Energi og transport

Portefølje Muliggjørende teknologier ikon

Muliggjørende teknologier

Portefølje Industri og tjenestenæringer ikon

Innovasjon

LTP2 Klima, miljø og miljøvennlig energi ikon

Klima, miljø og energi

LTP2 Samfunnssikkerhet og samhørighet ikon

Samfunnstryggleik og beredskap

LTP2 Fornyelse i offentlig sektor ikon

Velferdstjenester

Forsidebilde

Marin ikon

Petroleum og mineraler

LTP Hav ikon

Hav og kyst

LTP2 Muliggjørende og industrielle teknologier ikon

Mogleggjerande industrielle teknologiar

Tillit og fellesskap

LTP2 Utvikle fagmiljøer av fremragende kvalitet

Høg kvalitet og tilgjengeleg

LTP2 Styrket konkurransekraft og innovasjonsevne ikon

Sterkare konkurransekraft og innovasjonsevne

LTP3 Helse

Et innovativt næringsliv ikon

Styrket konkurransekraft og innovasjonsevne

Portefolje Petroleum Ikon

Portefølje Hav ikon

Portefølje Utdanning og kompetanse ikon

Portefølje Global utvikling og internasjonale relasjoner ikon

Portefølje Livsvitenskap ikon

Forsidebilde optimalisert

project-bank-technical

Muliggjørende teknologier bakgrunn

Marin bakgrunnsbilde

Statistikk

Prosjektbanken presenterer statistikk og informasjon om prosjekter med finansiering fra Forskningsrådet fra 2004. Statistikken er fordelt på blant annet tema, år, geografi og organisasjon. Prosjektbanken gir også detaljert informasjon om de enkelte prosjektene.

...eller se sammendrag og annen informasjon om prosjektene i utvalget ditt

Alle porteføljestyrer

En god beskrivelse av denne siden for søkemotoroptimalisering

Forside

Hvordan tildelingene fordeler seg på institusjoner, fylker, fagområder o.l....

Her er noen eksempler på søk du kan gjøre i Prosjektbanken

Alle langtidsplanmål

Veiledning: Hvordan bruke Prosjektbanken.no

Om Fritekstsøk

Ingen populærvitenskapelig framstilling tilgjengelig


Prosjektet med prosjektnummer {{project number}} ble ikke funnet

Teknisk beskrivelse

Oisann, her gikk noe galt. Kan du prøve å laste siden på nytt?  Dersom feilen vedvarer, vennligst kontakt oss.         

Se statistikk relatert til dette langtidsplanmålet

Se prosjekter relatert til dette langtidsplanmålet

knyttet til dette LTP-målet har blitt tildelt penger

har blitt tildelt til prosjekter knyttet til dette LTP-målet

har blitt tildelt til prosjekter knyttet til denne porteføljen

knyttet til denne porteføljen har blitt tildelt penger

Om Prosjektbanken

Kunnskapsdepartement

Diverse

Helse- og omsorgsdep

Kultur- og likestill

Medisin og helsefag

Oslo

LTP3 Styrket konkurransekraft og innovasjonsevne

LTP3 Innovasjon i stat og kommune

LTP3 Høy kvalitet og tilgjengelighet

LTP3 Fagmiljøer og talenter

LTP3 Tillit og fellesskap

LTP3 Velferdstjenester

Helseforetak

Portefølje Helse

Portefølje Innovasjon

Portefølje Velferd og utdanning

Portefølje Banebrytende forskning

Portefølje Forskningssystemet

Programmer

Frittstående prosjekter

Forprosjekt (t.o.m. 2019)

Koordinerings- og støtteaktivitet

Fornyelse og innovasjon i offentlig sektor

Politikk- og forvaltningsområder

Velferd, arbeidsliv og utdanning

Anvendt forskning

Tjenesterettet FoU

Internasjonalisering

Grunnforskning

Bilingual Experiences, Cognitive Ageing and underlying Mechanisms

The goal of the Bilingual Experiences, Cognitive Ageing and underlying Mechanisms (BECAME) project is to examine the functional neuroplastic mechanisms underlying mitigatory effects of bilingual experience on age-related cognitive decline. While evidence is available for structural brain changes supporting bilingualism-induced effects on cognitive aging (CA), functional mechanisms underlying such effects are not yet well understood. BECAME aims to fill this gap by investigating the trajectory of bilingualism-induced functional neuroplasticity across the adult lifespan (ages 18-85), crucially adopting an individual differences approach related to measurable degree of bilingual engagement. Importantly, although such benefits are thought to be rooted early in the lifespan, evidence for the timeframe and conditions of their early emergence is scarce. The choice of including the whole adult lifespan allows us to investigate these mechanisms and their emergence more directly from a lifespan perspective. I combine behavioral testing with brain recordings via electroencephalography (EEG). EEG is widely used in cognitive neuroscience to assess brain activity and the degree of communication between brain regions (functional connectivity) in response to stimuli and at rest. Combining behavioral and EEG modalities will allow me to test bilingualism’s effect on functional connectivity, as well as its consequences for functional efficiency, the minimum required neural activation to successfully perform a task. This will enable a detailed, evidence-based account of the protective effects observed in older-aged bilinguals, and how they are built from earlier life stages. By illuminating the relationship between multilingualism and resulting neurocognitive adaptations, BECAME will enable to capitalize on it as a health initiative, with manifold societal implications and the potential to be translated into actionable policies exploiting multilingualism to ameliorate effects of CA.

BOLD MINDS aspires to enhance the understanding of vulnerability factors underlying the emergence of borderline personality disorder (BPD), with an ultimate aim of increasing the potential for young individuals to receive early, evidence-based help when their mental health is at risk. BOLD MINDS will achieve this by investigating whether disruptions in two aspects of autobiographical memory (AM), narrative identity (NI) and involuntary AM (IAM), are associated with BPD features and problem behaviours in adolescents concurrently and over time. In doing so, BOLD MINDS will strengthen the understanding of mechanisms underlying the emergence of BPD in adolescence and lay a groundwork for developing evidence-based early interventions for BPD. While currently limited, the study of AM in this field is essential for two reasons. Firstly, because the aspects of AM under investigation, NI and IAM, are known to be involved in identity formation and emotion regulation which represent two key psychological processes that are disrupted in adults with BPD and are linked to problem behaviours such as self-harm and suicidality. Secondly, because promising research is emerging on the use of AM targets in the treatment of emotional disorder in adults, and provides a strong model for future treatment development with vulnerable adolescents. In addition, this timely research program aligns with calls from international organizations to prioritize early interventions to promote adolescent mental health. BOLD MINDS will adopt and adapt state-of-the-art ecological momentary assessment and analytical techniques and work at the crossroads of clinical and cognitive psychological perspectives, allowing for a multidimensional approach to understanding BPD vulnerability. Training-through-research and formalized training of the experienced researcher will prepare her for a permanent academic position and the founding of her own research lab specializing in AM and early interventions for BPD.

Borderline Personality Disorder: Memory and Identity in Adolescence

WHeelchair Activity Monitoring project (WHAM)

Wheelchair users (WCU) are three to five times more inactive than the general population, leading to a high risk of developing preventable secondary conditions. Although physical activity (PA) guidelines have been specifically developed for WCU, we lack systematic approaches to implement them in practice, as well as valid algorithms to monitor PA change in WCU through sensor-based solutions. Accordingly, the overall scientific aim of the WHeelchair Activity Monitoring project (WHAM) is to advance PA research and practice in WCU by developing valid digital markers for monitoring of and providing feedback on PA, paving the way for implementation and intervention. I will accomplish this through combining the complementary research fields of 1) behavioural intervention studies focusing on increasing PA in WCU (core competence University of British Columbia, UBC; outgoing phase) and 2) sensor-based PA monitoring (core competence Norwegian University of Science and Technology, NTNU; returning phase – consolidated by non-academic placement at Maastricht Instruments, which develop research prototypes including PA monitors). WHAM’s scientific aim is achieved through three objectives: 1) Measure the effect of a pragmatic exercise intervention trial on self-reported physical activity levels and cardio-respiratory fitness, 2) Develop valid algorithms for tracking PA markers in WCU, and 3) Co-create a framework that outlines how PA can be conjointly monitored and provided feedback on in WCU. This fellowship will enable me to become established as an internationally recognized researcher in the field of “physical activity and disability”, while bringing together ongoing national disjointed research activities in this field. Altogether, my overall ambition is to contribute to reducing inequalities in daily-life participation among WCU compared to the rest of the population.

Despites dental pulp capping materials should meet the certain requirements, the available materials have one or more shortcomings—poor biocompatibility and rheological properties, fail to maintain pulp vitality and to simulate reparative dentine formation and expensive etc. Mineral trioxide aggregate (MTA) is widely used material because of its beneficial properties. However, its composition bismuth oxide, which is suspectable to toxicity, has an impact on rheological properties. This emphasizes the necessity of looking for inexpensive alternatives to materials that meet the specifications. This project's goal and novelty are to investigate the potential processing of the dental pulp capping cement, which is made of strontium silicate (SrSiO3), strontium fluoride (SrF2), piezoelectric material (PZM) and tricalcium silicate (Ca3O5Si) and its rheological properties and hemocompatibility. Because SrSiO3, SrF2, PZM and Ca3O5Si have the promising properties. This project's work packages are split into four categories based on the interdisciplinary approach since it involves the synthesis and characterization of PZM, the processing and characterization of cement, the identification of rheological parameters utilizing ISO standardizations, and hemocompatibility, and acquiring new transferrable skills. Additionally, the interactions among the selected compounds will be determined. The scientific impact of this project is comprehending the physical properties and the immune system's response to evaluate the cement's suitability as a replacement for existing materials, as well as resulting in further uses in dentistry and medicine. The societal impact is providing millions of patients in Europe with predictable and outstanding treatment outcomes each year to maintain pulp vitality and health. Eventually, it will ease the financial load on millions of patients who need dental care, will be avoiding inflated medical expenses and misuse of the patent (economic impact).

SrSiO3-based Dental Pulp Capping Cement

Longitudinal Investigation of Visual and Numerical Perception in Preterm and Full-term Infants

The number of preterm births is on the rise -now more than 1 in 10 babies- and being born preterm is associated with having difficulties in two very important and related cognitive skills that we rely on daily: numerical and visual perception. However, a knowledge gap exists on neural and behavioural associations of numerical and visual perception in full-term and preterm infants. PrePER aims to uncover the underlying neural signatures of the cognitive dysfunctions that preterm infants might display in the first year of their lives and the role of parent-baby interaction to predict preterm infants that are at risk of developing these cognitive difficulties in the second year of their lives. The purpose is to establish criteria to identify infants (especially preterm) at-risk of having cognitive difficulties in numerical and visual perception. Shedding light on normal and impaired cognitive functions in infancy is an essential stepping stone that will pave the way for early diagnostic tools and interventions that would correct the cognitive dysfunctions more efficiently while the brain is still developing. The activities in PrePER will lead to original and innovative outcomes that are beneficial for four parties: 1) Scientific communities will be interested in the results as the ambitious research objectives address questions that have not been asked before. 2) Parents of preterm infants, health-care providers, and policy makers will be interested in the results as the overall aim is to establish criteria to identify infants at-risk of having cognitive-developmental difficulties in the first year of their lives. 3) The researcher will be accelerating her career progression as the training objectives meet her specific needs. 4) The supervisor will be enlarging her research interest and network as the research objectives include a topic within the researcher’s expertise.

AQUASERV – RESEARCH INFRASTRUCTURE SERVICES FOR SUSTAINABLE AQUACULTURE, FISHERIES AND THE BLUE ECONOMY

The overarching objectives of AQUASERV are to bring together, enhance, integrate and customise RI capacities (including facilities, instruments and expertise) and through the provision of transnational access (on-site or remote) and/or virtual access, to significantly further scientific advance and promote and facilitate the implementation of European Common Fisheries Policy, the Farm to Fork Strategy, the Sustainable Blue Economy and the European Green Deal.   AQUASERV will achieve these objectives by offering scientists from academia and business remote and on-site transnational (TA) and virtual (VA) access to an advanced set of European research infrastructures and its nodes related to research and management of marine and freshwater biological resources, food and biotechnology. These include the European Marine Biological Resource Centre ERIC (EMBRC), the Analysis and Experimentation on Ecosystems ERIC, The Aquaculture for Excellence for Aquaculture in Fish (Aquaexcel), and the Infrastructure for Promoting Metrology in Food and Nutrition (METROFOOD), as well as the International Council for Exploration of the Sea, both a service provider and stakeholder. It also includes the Research Infrastructure for Science and Innovation Policy Studies (RISIS) to bring contributions from the social sciences and to bring results nearer to policy makers ensuring societal impact.   To enhance, integrate and customise RI capacities, collaboration between partners and new pipelines to meet the objectives of the project will be developed during the first 3 years and will make available  to users.  To ensure these capacities will not be lost, a sustainability work package involving stakeholders will address the project legacy.    To maximize impact, AQUASERV will build a communication network among the partnership and develop a dissemination and outreach programme. Furthermore, an advanced training programme will be developed to capture future users and will be updated during the p

IMProving User experience, Long-term sustainability and Services of EU-OPENSCREEN

EU-OPENSCREEN (EU-OS), the distributed European Research Infrastructure for Chemical Biology and early drug discovery, provides world-class services in high-throughput compound screening and medicinal chemistry to users from academia and industry. As one of the largest open-access initiative globally, EU-OPENSCREEN plays an increasingly important role in facilitating early stage drug discovery in Europe. It recently integrated fragment-based drug discovery and chemoproteomics as two new services, but the increasing complexity of modern drug discovery projects requires an even more comprehensive portfolio and integration of emerging technologies. To ensure that EU-OS continues to offer a comprehensive suite of relevant services and support a growing user community to conduct forefront research, IMPULSE will develop, validate and integrate new services in AI/ML, new chemical modalities, and innovative disease-relevant cell models combined with CRISPR-Cas9/RNAi-based genetic screening. IMPULSE will work towards the implementation of common operational and data standards to increase data reproducibility and FAIRness. Bespoke outreach and training activities will raise awareness among key user groups of its new services and advance operational excellence and reproducibility in pre-clinical drug discovery. New models for pre-competitive drug discovery with industry or charities, and growing ERIC member community will reinforce the sustainability and accessibility of EU-OPENSCREEN.

Strengthening resilience and mental wellbeing through the Support4Resilience toolbox for leaders in elderly care

European elderly care experiences labor shortages, lack of qualified workers and a mismatch between capacity and demands, causing stress, burnout, and reduced mental wellbeing among healthcare workers and informal caregivers. Leaders are crucial in promoting supportive working conditions but lack research-based measures to act upon these challenges.  Support4Resilience (S4R) will develop, implement, and evaluate a research-based Toolbox to support healthcare leaders in improving healthcare workers’ and informal caregivers’ resilience and mental wellbeing in elderly care. S4R will identify resilience and mental wellbeing factors among healthcare workers and informal caregivers; explore their perspectives and needs; develop new theory on the relationship between individual and organizational resilience, and mental wellbeing; and develop recommendations and cost-effective interventions. The Toolbox with tailormade resources for policy and practical use will be available through an open access S4R Resource Bank.  The S4R Toolbox includes three main tools: 1) Mapping and identification, 2) Reflection and education, and 3) Reorganization. Measures are initiated at the organizational level and effects on mental wellbeing and resilience transpire at the frontline of elderly care. The Toolbox covers different situational contexts, types of healthcare providers and health system levels. Elderly care settings in six European countries will implement and evaluate the Toolbox through a process evaluation, effectiveness evaluation, and cost-effectiveness evaluation.   S4R provides policymakers, decisions-makers and leaders with solutions for taking action to solve specific risks for healthcare workers’ and informal caregivers’ resilience and mental wellbeing. Thus, pertinent to the work programme, S4R will support the development of resilient health systems in European elderly care through improved leadership capabilities, governance structures, and adaptive capacities.

NEXT GENERATION IMAGING FOR REAL-TIME DOSE VERIFICATION ENABLING ADAPTIVE PROTON THERAPY

The NOVO project will address a fundamental issue in proton radiotherapy (PT) of cancer, namely the lack of real-time dose verification (RDV) that significantly limits the potential of PT due to uncertainties in the precise delivery of the prescribed dose. In the NOVO project, we will develop the first proof-of-concept of an RDV technology adaptable to any PT treatment and bring the concept to TRL 4 by also considering integration into the PT clinical workflow. The RDV technology will be pivotal for enabling the next generation of adaptive PT therapy, i.e., dose-guided real-time adaptive therapy. Real-time measurement of the dose to targeted and non-targeted tissues will be the key to truly empower patient-centered, personalized cancer treatment, important to improve curation and quality-of-life post-treatment. As a high-risk/high-gain project, NOVO aims at a first-of-its-kind RDV technology through the unique synergy between (1) cutting-edge, inexpensive organic scintillator technology that can detect secondary radiation during treatment for non-invasive measurements, (2) novel and fast image reconstruction, artificial intelligence (AI)-accelerated models and AI-enhanced image reconstruction to allow simultaneous detection of multiple radiation species and tissue compositional analysis, (3) tumor-tracking and imaging of tissue radio-sensitivity based on oxygen levels, (4) intelligent automation of decision-making schemes for real-time dose-guided adaptive therapy. The project will essentially open a new era in PT that enables curing more cancer patients and reducing toxicity from treatment. The NOVO consortium covers the entire value chain of RDV development (technology providers, theory and modelling, technology integration and PT clinics) and optimally engages nuclear, medical, and high-energy physicists, chemists, mathematicians, computer scientists, oncologists, biologists, as well as European PT centers.  

Development of innovative proton and neutron therapies with high cancer specificity by 'hijacking' the intracellular chemistry of haem biosynthesis.

Deep-lying cancers, such as glioblastoma multiforme (GBM) brain cancer, are very difficult to access and incurable by the current standards of care. The fluorescence of photosensitive molecules (PSs) can precisely guide surgical resection of GBM. Nevertheless, photomedical treatments like photodynamic therapy (PDT) show limited efficacies due to the low penetration of light into tissue. Proton radiotherapy can reach deep-lying disease through therapeutic energy deposition in a spatially confined region called Bragg peak. Current neutron-based therapies, like Boron Neutron Capture Therapy (BNCT), have sufficient penetration depth but lack cancer specificity. In NuCapCure, we propose to 'hijack' intracellular biosynthetic pathways and use them to produce custom-made drugs that will facilitate two genuinely new cancer treatments: i) "NuCapCure Proton", combining proton radiotherapy, protondynamic therapy through PS proton activation, and proton capture therapy (BPCT) through three produced alpha particles; and ii) "NuCapCure neutron", combining GBM specific BNCT and PS neutron activation as demonstrated in our FET-open project FRINGE. The main scientific breakthroughs of NuCapCure will be to demonstrate the custom production of novel compounds through native intracellular biosynthesis but also to establish experimental proof-of-principle, both in vitro and in vivo, of the proposed two novel therapies. Our highly interdisciplinary project team comprises world-renowned experts from a unique combination of disciplines: proton and neutron physics, synthetic chemistry, photochemistry, photobiology, radiobiology, medical physics, nuclear reactor and particle accelerator technology and radio-oncology to lay the foundations for novel, targeted and curative therapies against currently fatal cancer indications like GBM.

Midlene fra CL5-Climate, Energy and Mobility fordelt på år

Midlene fra CL5-Climate, Energy and Mobility fordelt på fylker

Midlene fra CL5-Climate, Energy and Mobility fordelt på fagområde

Circular Economy Modelling for Climate Change Mitigation

Decarbonizing the production and consumption of products and materials play a critical role in reaching ambitious climate targets. As a result, a new circular economic system that aims to reduce primary material use (in addition to energy efficiency and fuel shifts) can address both Greenhous Gas emissions (GHG)s and increase resource efficiency. However, current GHG mitigation models and scenarios that inform climate policymakers do not generally include circular economy (CE) options. They also do not cover the possible synergies of the CE with other societal goals such as the Sustainable Development Goals (SDGs), nor the challenges involved in rearranging value chains and consumer behaviour.  CIRCOMOD addresses these challenges by developing a new generation of advanced models and scenarios that will assess how CE can reduce future GHGs and material use. The project brings together a unique consortium of leading research teams from different disciplines, including industrial ecology and material flow modelling, process-oriented integrated assessment modelling, and macro-economic modelling. It aims for a breakthrough in integrating CE and GHG mitigation assessments by developing an analytical framework that maps circular economy strategies to existing influential climate scenarios; by providing robust and timely CE data in an open repository; and, by improving the representation of the CE in leading models used by European and global institutions, while strengthening links between the models. These key scientific breakthroughs enable robust scientific assessments in collaboration with stakeholders across policy and industry. It will provide timely input to international assessments such as the Intergovernmental Panel on Climate Change (IPCC) and the International Resource Panel (IRP). CIRCOMOD will provide actionable insights into the circular economy and help address one of the largest challenges of the coming decades.

Akutt sykdom eller skade kan medføre akutte mentale endringer, og dette betegnes et delirium. Delirium er en tilstand karakterisert av akutt oppstått kognitiv endring, oppmerksomhetssvikt og endret bevissthetsnivå. Symptomene har en tendens til å svinge gjennom døgnet. Selv om alle mennesker kan utvikle et delirium i forbindelse med akutte hendelser, er eldre personer og personer med demens, mest utsatt. Blant eldre personer innlagt i sykehus opplever omtrent 30% et delirium, og nesten 50% av hoftebruddspasienter har delirium i forbindelse med bruddet. Utvikling av delirium er assosiert med økt risiko for varig funksjonssvikt, og økt risiko for utvikling av demens eller forverring av eksisterende demenssykdom. En god forståelse av de underliggende mekanismene om hvordan et delirium oppstår, finnes ikke. Utover å behandle den utløsende årsaken til deliriet, eksisterer det ingen god behandling av delirium.

Den 12. europeiske deliriumskongress ble avholdt i Oslo den 16. og 17. november, 2017. Kongressen samlet 249 deltagere fra 24 land. Da dette var en europeisk kongress, var de fleste deltagere fra det europeiske kontinent. Men det var i tillegg 18 deltagere fra Nord-Amerika, og 17 deltagere fra Australia/New Zealand.

Fra 2006 har den eruopeiske deliriumskongress blitt arrangert hvert år. Kongressen har i gjennomsnitt hatt 250 deltakere fra ulike europeiske land. I tillegg er deltakere fra USA og Australia ofte representert. 

Oslo Delirium Research Group er blitt forespurt av det europeiske styret om å arrangere kongressen høsten 2017. Dette har vi takket ja til, og kongressen vil avholdes på Hotell Bristol, Oslo, fra 16.-17. november 2017.

12th Annual Meeting of the European Delirium Association, Oslo, Norway

I forprosjektet ønsker vi å planlegge et forskningsprosjekt som kan frembringe en ny metode for å diagnostisere delirium hos skrøpelige pasienter med kjent kognitiv svikt til bruk i sykehjem, samt blant hjemmeboende eldre med hjemmesykepleie. Hovedmålet er å utviklet et verktøy som evner å skille delirium fra atferdsforstyrrelser og psykiatriske symptomer ved demens (APSD). 
Vi ønsker å implementere denne metoden for bruk i daglig observasjon ved tegn til akutte endringer, samt ha et fokus på viktigheten av å formidle kognitive endringer i samhandling mellom ulike deler av helsetjenester. 
Nytteverdien vil være økt sannsynlighet for tidlig å oppdage delirium hos pasienter med kjent kognitiv svikt. Da delirium skyldes en underliggende somatisk årsak er det viktig å tidlig oppdage dette, med mulighet for å korrigere underliggende tilstand med påfølgende tilbakegang av den akutte kognitive endring. 
Forskerprosjektet er tenkt gjennomført i tre deler:
1. Metodeutvikling basert på informasjon fra pasienter, pårørende og personale 
2. Implementering av en modell 
3. Evaluering av modell med hovedvekt på effekt på kommunikasjon og samhandling mellom ulike deler av helsetjenesten.
4. En naturlig videreføring av prosjektet vil være en behandlingsintervensjon der man undersøker hvorvidt tidlig diagnostikk kan medføre raskere behandling, redusert risiko for funksjonstap, og reduserte kostnader.

Prosjektet vil være organisert ved at pasienter bosatt i sykehjem og i hjemmet vil bli inkludert fra to separate kommuner; pasienter i sykehjem vil bli inkludert fra Oslo kommune, mens hjemmeboende pasienter med hjemmetjeneste vil bli inkludert fra Sandefjord kommune.

0 antall prosjekter

FRIMEDBIO-Fri prosj.st. med.,helse,biol

12th Annual Meeting of the European Delirium Association, Oslo, Norway

Tildelt: kr 0,17 mill.

Prosjektperiode: 2017-2017

Sted: Oslo

BEHANDLING-God og treffsikker diagnostikk, behandling og rehabilitering

The interface between behavioural and psychological symptoms of dementia, and delirium: Development of a new diagnostic approach

Tildelt: kr 0,21 mill.

Prosjektperiode: 2016-2017

Sted: Oslo